Sensitive Cardiac Troponin T Assay and the Risk of Incident Cardiovascular Disease in Women With and Without Diabetes Mellitus
- 21 June 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 123 (24) , 2811-2818
Abstract
Background—: Very low levels of cardiac troponin T are associated with an increased risk of cardiovascular death in patients with stable chronic coronary disease. Whether high-sensitivity cardiac troponin T levels are associated with adverse cardiovascular outcomes in individuals without cardiovascular disease (CVD) has not been well studied. Methods and Results—: Using 2 complementary study designs, we evaluated the relationship between baseline cardiac troponin and incident CVD events among diabetic and nondiabetic participants in the Women's Health Study (median follow-up, 12.3 years). All diabetic women with blood specimens were included in a cohort study (n=512 diabetic women, n=65 events), and nondiabetic women were sampled for inclusion in a case-cohort analysis (n=564 comprising the subcohort, n=479 events). High-sensitivity cardiac troponin T was detectable (≥0.003 μg/L) in 45.5% of diabetic women and 30.3% of nondiabetic women ( P 1c , detectable high-sensitivity cardiac troponin T was associated with subsequent CVD (myocardial infarction, stroke, cardiovascular death) in diabetic women (adjusted hazard ratio, 1.79; 95% confidence interval, 1.04 to 3.07, P =0.036) but not nondiabetic women (adjusted hazard ratio, 1.13; 95% confidence interval, 0.82 to 1.55; P =0.46). Further adjustment for amino-terminal pro-B-type natriuretic peptide and estimated renal function did not substantially alter this relationship among diabetic women (hazard ratio, 1.76; 95% confidence interval, 1.00 to 3.08; P =0.0499), which appeared to be driven by a 3-fold increase in CVD death that was not observed in nondiabetic women. Conclusions—: Very low but detectable levels of cardiac troponin T are associated with total CVD and CVD death in women with diabetes mellitus. Among healthy nondiabetic women, detectable compared with undetectable troponin was not associated with CVD events.Keywords
This publication has 29 references indexed in Scilit:
- Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General PopulationJAMA, 2010
- Association of Serial Measures of Cardiac Troponin T Using a Sensitive Assay With Incident Heart Failure and Cardiovascular Mortality in Older AdultsJAMA, 2010
- Temporal association of elevations in serum cardiac troponin T and myocardial oxidative stress after prolonged exercise in ratsEuropean Journal of Applied Physiology, 2010
- Blood Pressure Control in Type 2 DiabetesNew England Journal of Medicine, 2010
- Combination Lipid Therapy in Type 2 DiabetesNew England Journal of Medicine, 2010
- A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in WomenNew England Journal of Medicine, 2005
- Metabolic Abnormalities in the Diabetic HeartHeart Failure Reviews, 2002
- Analysis of Case-Cohort DesignsJournal of Clinical Epidemiology, 1999
- Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1996
- The Prognostic Value of Serum Troponin T in Unstable AnginaNew England Journal of Medicine, 1992